SOQLADIC Trademark

Trademark Overview

On Friday, March 27, 2026, a trademark application was filed for SOQLADIC with the United States Patent and Trademark Office. The USPTO has given the SOQLADIC trademark a serial number of 99728947. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 27, 2026. This trademark is owned by AstraZeneca AB. The SOQLADIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes
soqladic

General Information

Serial Number99728947
Word MarkSOQLADIC
Filing DateFriday, March 27, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, March 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 27, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSodertalje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, March 27, 2026NEW APPLICATION ENTERED
Friday, March 27, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 27, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

soqladic pharmaceutical preparations disorders diseases treatment hematological infection inflammation autoimmune antibodies